GKIM
PBH icon

GW&K Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

GW&K Investment Management’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-106
Closed -$9K – 1022
2025
Q1 		$9K Buy
+106
New +$8.7K ﹤0.01% 839

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GW&K Investment Management's PBH Position: Q2 2025 in Review

GW&K Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2025, closing a stake of 106 shares — an estimated $9K sold.

GW&K Investment Management first reported a position in PBH in Q1 2025 and held it in 1 quarter. The position peaked at $9K in Q1 2025. 378 funds tracked by Wall St. Rank hold PBH as of Q2 2025.

  • GW&K Investment Management reported no remaining Prestige Consumer Healthcare position as of Q2 2025 after selling out during the quarter.
  • GW&K Investment Management sold 106 Prestige Consumer Healthcare shares in Q2 2025, an estimated $9K.
  • GW&K Investment Management first reported a position in Prestige Consumer Healthcare in Q1 2025 and held it in 1 quarter.
  • GW&K Investment Management's Prestige Consumer Healthcare position peaked at $9K in Q1 2025.
  • 378 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2025.

Based on GW&K Investment Management's 13F filing for Q2 2025, filed 11 Aug 2025.